As the impact of Biologics on society and the economy increases-just ask Steve Forbes-so too must the patient guard against charlatans, fraud and medical abuse. Musculoskeletal injury is the most common cause for emergency room visits worldwide, resulting in millions of hours of lost work and at a cost of billions of dollars each year. Orthopedic surgeons and physicians have traditionally relied upon metal prostheses, plastic implants, and synthetic fluid injections to repair and replace torn tissue and to ease the pain of arthritis. There continues to be tremendously exciting progress using stem cells and biologic agents to treat tissue damage. These treatment options help ease pain, suffering and allow optimal rehabilitation of the injured and arthritic patient without surgery. How is a patient with musculoskeletal injury or limited by arthritis able to choose the right physician in this ever-changing landscape of Regenerative Medicine and Cellular Orthopedics?
Let’s start with Regenexx and the ongoing research as well as scientific publications informing the patient as well as other physicians about the Outcomes of Regenerative Medicine interventions. Just navigate the Regenexx.com web site to see how they are the leader in data collection and outcomes surveillance with an ever increasing Data Base and experience. Then there are the Linked-In exchanges with Regenexx in which I participate ever increasing my knowledge base and assuring that my procedures remain at the forefront of this rapidly expanding specialty of medicine. As many readers of this Blog are aware, I maintain a very active data collection program allowing me to continually monitor the outcomes of my Cellular Orthopedic activities. The truth be told, we are in the forefront.
Last Thursday, I received recognition form the Board of Trustees of Rush University Medical Center for my years of “faithful and dedicated service as a member of the of the Medical Staff.” My academic rank is Emeritus Professor in the Department of Orthopaedic Surgery. While the recognition was for services rendered as a joint replacement surgeon, today my mission is to help a patient postpone or possible avoid a new hip or knee through Stem Cell intervention.
Tags: arthritis, athletes, Bone Marrow Concentrate, Clinical Trial. Mitchell B. Sheinkop, Interventional Orthopedics, joint replacement, Knee, Mature Athlete, Osteoarthritis, Regenerative, Regenexx, stem cells